Expertise in
13
conditions

Dr. Nima Nabavizadeh

Radiation Oncology
OHSU Hospital
3181 SW Sam Jackson Park Rd, 
Portland, OR 
Accepting New Patients
Offers Telehealth
Expertise in
13
conditions
OHSU Hospital
3181 SW Sam Jackson Park Rd, 
Portland, OR 

Overview

Nima Nabavizadeh is a Radiation Oncologist practicing medicine in Portland, Oregon.

Dr. Nabavizadeh is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Melanoma of the Eye, Plasmacytoma, and Choroid Plexus Carcinoma.

He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 5 clinical trials. Dr. Nabavizadeh is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in OR

Hospital Affiliations

Columbia Memorial Hospital
Ohsu Hospital And Clinics
Hillsboro Medical Center
Samaritan North Lincoln Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

OHSU Hospital
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Other Locations
OHSU Cho Beaverton
15700 SW Greystone Ct, Beaverton, OR 97006
Oregon Health And Science University School Of Medicine Radiology
3181 Sw Sam Jackson Park Rd, Portland, OR 97239

Additional Areas of Focus

Dr. Nabavizadeh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase 1b Study to Assess the Safety of Neoadjuvant TAS-102 (Trifluridine/Tipiracil) With Concurrent Radiation in Previously Untreated Resectable Stage II and Stage III Rectal Cancer (FIERCE)
Phase 1b Study to Assess the Safety of Neoadjuvant TAS-102 (Trifluridine/Tipiracil) With Concurrent Radiation in Previously Untreated Resectable Stage II and Stage III Rectal Cancer (FIERCE)
Enrollment Status: Completed
Publish Date: August 06, 2026
Intervention Type: Drug, Radiation
Study Phase: Phase 1
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Fluorouracil, Mitomycin
Study Phase: Phase 2
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 23, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Pilot Study to Assess Feasibility of Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation
A Pilot Study to Assess Feasibility of Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation
Enrollment Status: Terminated
Publish Date: March 07, 2025
Intervention Type: Other, Radiation
Study Phase: Not Applicable
Randomized Prospective Two-Arm Feasibility Trial of Stereotactic Body Radiation Therapy Versus Yttrium-90 Segmentectomy in Inoperable Hepatocellular Carcinoma
Randomized Prospective Two-Arm Feasibility Trial of Stereotactic Body Radiation Therapy Versus Yttrium-90 Segmentectomy in Inoperable Hepatocellular Carcinoma
Enrollment Status: Withdrawn
Publish Date: March 23, 2023
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 2
View 4 Less Clinical Trials

72 Total Publications

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 15, 2026
Similar Doctors
Expertise in
21
conditions
Dr. Arthur Y. Hung
Radiation Oncology
Expertise in
21
conditions
Dr. Arthur Y. Hung
Radiation Oncology
Referral may be required

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
 (0.1 miles away)
503-494-8756
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Arthur Hung is a Radiation Oncologist practicing medicine in Portland, Oregon. Dr. Hung is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Prostatectomy, and Orchiectomy. Dr. Hung is currently accepting new patients.

Expertise in
9
conditions
Dr. Timur E. Mitin
Radiation Oncology
Expertise in
9
conditions
Dr. Timur E. Mitin
Radiation Oncology
Referral may be required

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timur Mitin is a Radiation Oncologist practicing medicine in Portland, Oregon. Dr. Mitin is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Small Cell Lung Cancer (SCLC), Familial Prostate Cancer, Prostatectomy, and Orchiectomy. Dr. Mitin is currently accepting new patients.

Expertise in
16
conditions
Dr. Stephen B. Bader
Radiation Oncology
Expertise in
16
conditions
Dr. Stephen B. Bader
Radiation Oncology
Referral may be required
4805 Ne Glisan St, Garden Level, 
Portland, OR 
 (4.0 miles away)
503-215-6029
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stephen Bader is a Radiation Oncologist practicing medicine in Portland, Oregon. Dr. Bader is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Bader is currently accepting new patients.

Frequently Asked Questions about Dr. Nima Nabavizadeh

How do I make an appointment with Dr. Nima Nabavizadeh?

You can book an appointment with Dr. Nima Nabavizadeh by calling their office at 503-494-8756. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Nima Nabavizadeh a top-rated expert for Pancreatic Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nima Nabavizadeh is classified as an Distinguished expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Nima Nabavizadeh specialize in?

While Dr. Nima Nabavizadeh is a Radiation Oncology, they have specific expertise in Pancreatic Cancer, Melanoma of the Eye, and Plasmacytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Nima Nabavizadeh participate in research or clinical trials?

Yes. Dr. Nima Nabavizadeh has published 72 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Dr. Nima Nabavizadeh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Nima Nabavizadeh accept my insurance?

Dr. Nima Nabavizadeh accepts most major insurance plans, including BridgeSpan and Cambia Health Solutions. We recommend calling the office directly at 503-494-8756 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nabavizadeh's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile